53 related articles for article (PubMed ID: 12750274)
1. Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo.
Maggiorella L; Deutsch E; Frascogna V; Chavaudra N; Jeanson L; Milliat F; Eschwege F; Bourhis J
Cancer Res; 2003 May; 63(10):2513-7. PubMed ID: 12750274
[TBL] [Abstract][Full Text] [Related]
2. XAV939-mediated ARTD activity inhibition in human MB cell lines.
Renna C; Salaroli R; Cocchi C; Cenacchi G
PLoS One; 2015; 10(4):e0124149. PubMed ID: 25835728
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of Cetuximab-Induced Radiosensitization by JAK-1 Inhibition.
Bonner JA; Trummell HQ; Bonner AB; Willey CD; Bredel M; Yang ES
BMC Cancer; 2015 Oct; 15():673. PubMed ID: 26458879
[TBL] [Abstract][Full Text] [Related]
4. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
Bol GM; Vesuna F; Xie M; Zeng J; Aziz K; Gandhi N; Levine A; Irving A; Korz D; Tantravedi S; Heerma van Voss MR; Gabrielson K; Bordt EA; Polster BM; Cope L; van der Groep P; Kondaskar A; Rudek MA; Hosmane RS; van der Wall E; van Diest PJ; Tran PT; Raman V
EMBO Mol Med; 2015 May; 7(5):648-69. PubMed ID: 25820276
[TBL] [Abstract][Full Text] [Related]
5. Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts.
Ji J; Dragojevic S; Callaghan CM; Smith EJ; Talele S; Zhang W; Connors MA; Mladek AC; Hu Z; Bakken KK; Sarkaria PP; Carlson BL; Burgenske DM; Decker PA; Rashid MA; Jang MH; Gupta SK; Eckel-Passow JE; Elmquist WF; Sarkaria JN
Mol Cancer Ther; 2024 May; 23(5):662-671. PubMed ID: 38224566
[TBL] [Abstract][Full Text] [Related]
6. Aminated laminaran from brown alga Saccharina cichorioides: Synthesis, structure, anticancer, and radiosensitizing potential in vitro.
Malyarenko OS; Usoltseva RV; Silchenko AS; Ermakova SP
Carbohydr Polym; 2020 Dec; 250():117007. PubMed ID: 33049875
[TBL] [Abstract][Full Text] [Related]
7. Triggering Breast Cancer Apoptosis via Cyclin-Dependent Kinase Inhibition and DNA Damage by Novel Pyrimidinone and 1,2,4-Triazolo[4,3-
Abd Al Moaty MN; El Kilany Y; Awad LF; Soliman SM; Barakat A; Ibrahim NA; Abu-Serie MM; Haukka M; El-Yazbi A; Teleb M
ACS Omega; 2024 May; 9(19):21042-21057. PubMed ID: 38764636
[TBL] [Abstract][Full Text] [Related]
8. RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypes.
Pesch AM; Hirsh NH; Michmerhuizen AR; Jungles KM; Wilder-Romans K; Chandler BC; Liu M; Lerner LM; Nino CA; Ward C; Cobain EF; Lawrence TS; Pierce LJ; Rae JM; Speers CW
JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34932500
[TBL] [Abstract][Full Text] [Related]
9. Modulating the Radiation Response for Improved Outcomes in Breast Cancer.
Pesch AM; Pierce LJ; Speers CW
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250414
[No Abstract] [Full Text] [Related]
10. Peptide-Functionalized Nanoparticles-Encapsulated Cyclin-Dependent Kinases Inhibitor Seliciclib in Transferrin Receptor Overexpressed Cancer Cells.
He GZ; Lin WJ
Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33803751
[TBL] [Abstract][Full Text] [Related]
11. Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer.
Hermanowicz JM; Szymanowska A; Sieklucka B; Czarnomysy R; Pawlak K; Bielawska A; Bielawski K; Kalafut J; Przybyszewska A; Surazynski A; Rivero-Muller A; Mojzych M; Pawlak D
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):535-548. PubMed ID: 33522320
[TBL] [Abstract][Full Text] [Related]
12. Histamine H3 Receptor Promotes Cell Survival via Regulating PKA/CREB/CDKN1A Signal Pathway in Hepatocellular Carcinoma.
Zhang C; Yu Y; Ma L; Fu P
Onco Targets Ther; 2020; 13():3765-3776. PubMed ID: 32440145
[TBL] [Abstract][Full Text] [Related]
13. Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers.
Lin ZP; Zhu YL; Ratner ES
Front Oncol; 2018; 8():303. PubMed ID: 30135856
[TBL] [Abstract][Full Text] [Related]
14. Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines.
Ziemann F; Seltzsam S; Dreffke K; Preising S; Arenz A; Subtil FSB; Rieckmann T; Engenhart-Cabillic R; Dikomey E; Wittig A
Oncotarget; 2017 Dec; 8(62):105170-105183. PubMed ID: 29285242
[TBL] [Abstract][Full Text] [Related]
15. Residual Cdk1/2 activity after DNA damage promotes senescence.
Müllers E; Silva Cascales H; Burdova K; Macurek L; Lindqvist A
Aging Cell; 2017 Jun; 16(3):575-584. PubMed ID: 28345297
[TBL] [Abstract][Full Text] [Related]
16. The plant-specific CDKB1-CYCB1 complex mediates homologous recombination repair in Arabidopsis.
Weimer AK; Biedermann S; Harashima H; Roodbarkelari F; Takahashi N; Foreman J; Guan Y; Pochon G; Heese M; Van Damme D; Sugimoto K; Koncz C; Doerner P; Umeda M; Schnittger A
EMBO J; 2016 Oct; 35(19):2068-2086. PubMed ID: 27497297
[TBL] [Abstract][Full Text] [Related]
17. Roscovitine in cancer and other diseases.
Cicenas J; Kalyan K; Sorokinas A; Stankunas E; Levy J; Meskinyte I; Stankevicius V; Kaupinis A; Valius M
Ann Transl Med; 2015 Jun; 3(10):135. PubMed ID: 26207228
[TBL] [Abstract][Full Text] [Related]
18. Prevention of radiation-induced salivary gland dysfunction utilizing a CDK inhibitor in a mouse model.
Martin KL; Hill GA; Klein RR; Arnett DG; Burd R; Limesand KH
PLoS One; 2012; 7(12):e51363. PubMed ID: 23236487
[TBL] [Abstract][Full Text] [Related]
19. CDKB2 is involved in mitosis and DNA damage response in rice.
Endo M; Nakayama S; Umeda-Hara C; Ohtsuki N; Saika H; Umeda M; Toki S
Plant J; 2012 Mar; 69(6):967-77. PubMed ID: 22092531
[TBL] [Abstract][Full Text] [Related]
20. The Role of Pharmacokinetics and Pharmacodynamics in Early Drug Development with reference to the Cyclin-dependent Kinase (Cdk) Inhibitor - Roscovitine.
Hassan M; Sallam H; Hassan Z
Sultan Qaboos Univ Med J; 2011 May; 11(2):165-78. PubMed ID: 21969887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
